ArticleClinical journal of gastroenterology2025

Pathological complete response following addition of durvalumab to gemcitabine and cisplatin therapy for intrahepatic cholangiocarcinoma with Lynch syndrome-associated mismatch repair deficiency.

Koshiro Fukuda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.